Insights

Double Fortified Salt Manufacturing: Key Technical Challenges Revealed

4 August 2026 · 7 min read · NutraX Biotech Editorial Team

Cover image for: Double Fortified Salt Manufacturing: Key Technical Challenges Revealed
Cover image for: Double Fortified Salt Manufacturing: Key Technical Challenges Revealed

FSSAI requires double fortified salt (DFS) to contain at least 14 mg elemental iron (as ferrous fumarate) and 25 mg iodine per kg final salt under the FSS (Fortification of Foods) Regulations, 2018. However, manufacturing DFS to stable, compliant specifications uncovers significant technical challenges most suppliers do not openly disclose, particularly regarding nutrient uniformity, stability, and scale-up.

Iron-Iodine Compatibility: The Core Technical Barrier

The primary technical hurdle in DFS manufacturing is preventing iron and iodine from interacting adversely, causing instability and nutrient loss. Scientific studies and field trials have documented iodine losses exceeding 30% when DFS is exposed to high humidity or improper storage, predominantly due to iron-catalyzed oxidation. FSSAI mandates iron in DFS must be in a stable form like microencapsulated ferrous fumarate, and such microencapsulation must maintain at least 90% retention of both nutrients over 6 months under ambient Indian conditions (typically 35–45°C, 70% RH). Most generic blending or non-encapsulated iron systems simply cannot achieve this, risking non-compliance and label failure at shelf.

Precision Blending and Homogeneity: Meeting Rigorous Standards

Uniform nutrient distribution is non-negotiable in DFS, as per FSSAI’s tolerance limits. Achieving ≥98% homogeneity in the iron-iodine premix phase is essential to ensure every dose of final salt delivers the prescribed 14 mg iron and 25 mg iodine per kg. This requires industrial-scale ribbon blenders validated for mixing times and critical process parameters. For reference, particle size of iron (150–250 μm for encapsulated ferrous fumarate) and pure potassium iodate (<100 μm) must be considered to reduce segregation. Procurement managers should demand homogeneity data; spot checks at NutraX’s Faridabad facility indicate a coefficient of variation (CV) below 5% in final batch testing, which equates to industry best practice.

Microencapsulation: Engineering Stability for Shelf Life

Micronutrient and salt chemistries can rapidly degrade without protective technologies. In DFS, fluid-bed or spray-congealing microencapsulation of ferrous fumarate is used to shield iron from reacting with iodine and environmental moisture. Technical literature and NutraX Biotech’s own process validation have shown encapsulation efficiency exceeding 95% for iron, with effective reduction of iron- and iodine-related off-flavors. For high-volume B2B supply, the encapsulation process must produce particle sizes between 150–250 μm to align with common Indian and African salt granulometry, preventing sifting or layer separation in transit and in the finished product. Modern encapsulation lines can process >2 metric tonnes/day at consistent quality, but require critical control throughout to avoid under- or over-coating, which would impact both efficacy and regulatory compliance.

Analytical Verification: Ensuring Compliance and Traceability

Every batch of DFS supplied to Indian or export markets must undergo laboratory verification for both iron and iodine content at the point of packing, as well as retention over shelf life. FSSAI’s guidelines require at least 90% of both nutrients at end of shelf, with initial batch values typically set with a 10–20% overrun to compensate for known process and storage loss. NutraX Biotech's in-house analytical lab conducts spectrophotometric analysis on every production lot, with certificates of analysis (COAs) tracing values (iron: 16–20 mg/kg, iodine: 28–32 mg/kg for DFS premix batches at release). For procurement and compliance teams, full COA traceability and ongoing shelf-life testing are non-optional.

Process Controls and Packaging: Addressing Real-World Logistics

Process control doesn't end at mixing. Even after microencapsulation, DFS remains sensitive to environmental exposure. Relative humidity over 60% can significantly accelerate iodine volatilization, and iron can still migrate in poorly controlled storage, especially in bulk transports exceeding one week. At NutraX Biotech, DFS blends are packaged in a cleanroom within multi-layer, high-barrier polyethylene sacks, each batch immediately tested for residual moisture (<1.5% w/w). Export-bound DFS may require heat-sealed, 3-ply laminate packaging—a standard that reduces nutrient loss in African and Southeast Asian transit by up to 25% compared to conventional bags. Procurement managers should require specific packaging and transit validation data for each market.

Overrun Calculations: Compensating for Losses and Maintaining Regulatory Compliance

Both iron and iodine degrade during processing, storage, and consumer use. In practice, DFS manufacturers add 5–20% overrun for iron, depending on the salt matrix, and 10% for iodine to ensure compliance with FSSAI minimums at end of shelf life. For example, a DFS plant targeting 14 mg iron/kg at shelf will typically blend to 16–17 mg/kg at pack-off. Accurate overrun requires pilot-scale degradation data and rigorous stability testing. Without data-driven overruns, DFS at retail end can fall below regulatory thresholds, risking recall or contract breaches—an especially acute issue in government tender programs which may sample for compliance up to 12 months post-delivery.

Secondary suppliers or spot-market traders often fail to disclose these technical realities, leaving buyers exposed to out-of-spec deliveries, unstable product at shelf, or regulatory non-compliance. Procurement professionals must demand batch COAs, blending and microencapsulation validation, as well as shelf-life traceability data—not only initial specification sheets.

Key Takeaways

• Achieving ≥98% homogeneity in DFS premixes is challenging but essential for regulatory compliance and quality, demanding validated ribbon blending and analytical confirmation.

• Stabilizing iron and iodine together in salt requires precise microencapsulation and fluid-bed coating—without robust process control, up to 30% iodine loss can occur in storage.

• Accurate vitamin and mineral overrun (5–20% for some nutrients) is vital to compensate for processing and shelf-life losses, as mandated by FSSAI for DFS meeting population health requirements.

Ultimately, sustainable, compliant double fortified salt manufacturing is a blend of validated technology, tight process control, and robust traceability—not an off-the-shelf commodity. For procurement managers, the true cost of unstable or out-of-spec DFS is reputational and regulatory—not just financial. Partner only with suppliers who demonstrate mastery across blending, stability, overrun calculation, and compliance analytics, supported with hard batch data. Your program’s impact—and your end-user’s health—depend on it.

NB

NutraX Biotech Editorial Team

Published 4 August 2026

ShareLinkedInEmail